-
1
-
-
0034796617
-
FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models
-
Mochizuki T, Tsukamoto E, Kuge Y, Kanegae K, Zhao S, Hikosaka K, et al. FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models. J Nucl Med 2001;42:1551-5.
-
(2001)
J. Nucl Med.
, vol.42
, pp. 1551-1555
-
-
Mochizuki, T.1
Tsukamoto, E.2
Kuge, Y.3
Kanegae, K.4
Zhao, S.5
Hikosaka, K.6
-
2
-
-
0029092229
-
Glucose transporter gene expression: Regulation of transcription and mRNA stability
-
McGowan KM, Long SD, Pekala PH. Glucose transporter gene expression: Regulation of transcription and mRNA stability. Pharmacol Ther 1995;66:465-505.
-
(1995)
Pharmacol. Ther.
, vol.66
, pp. 465-505
-
-
McGowan, K.M.1
Long, S.D.2
Pekala, P.H.3
-
3
-
-
0032962081
-
Oncological applications of FDG PET imaging: Brain tumors, colorectal cancer, lymphoma, and melanoma
-
Delbeke D. Oncological applications of FDG PET imaging: Brain tumors, colorectal cancer, lymphoma, and melanoma. J Nucl Med 1999;40:591-603.
-
(1999)
J. Nucl Med.
, vol.40
, pp. 591-603
-
-
Delbeke, D.1
-
4
-
-
0035132776
-
Glucose metabolism of breast cancer assessed by 18F-FDG PET: Histologic and immunohistochemical tissue analysis
-
Avril N, Menzel M, Dose J, Schelling M, Weber W, Jänicke F, et al. Glucose metabolism of breast cancer assessed by 18F-FDG PET: Histologic and immunohistochemical tissue analysis. J Nucl Med 2001;42:9-16.
-
(2001)
J. Nucl Med.
, vol.42
, pp. 9-16
-
-
Avril, N.1
Menzel, M.2
Dose, J.3
Schelling, M.4
Weber, W.5
Jänicke, F.6
-
5
-
-
0028519891
-
Cancer or inflammation? A holy grail for nuclear medicine
-
Larson SM. Cancer or inflammation? A holy grail for nuclear medicine. J Nucl Med 1994;35:1653-5.
-
(1994)
J. Nucl Med.
, vol.35
, pp. 1653-1655
-
-
Larson, S.M.1
-
6
-
-
10744232930
-
Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: Analysis of false-positive FDG-PET findings
-
Konishi J, Yamazaki K, Tsukamoto E, Tamaki N, Onodera Y, Otake T, et al. Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: Analysis of false-positive FDG-PET findings. Respiration 2003;70:500-6.
-
(2003)
Respiration
, vol.70
, pp. 500-506
-
-
Konishi, J.1
Yamazaki, K.2
Tsukamoto, E.3
Tamaki, N.4
Onodera, Y.5
Otake, T.6
-
7
-
-
13944283362
-
Fluorodeoxyglucose-PET in characterizing solitary pulmonary nodules, assessing pleural diseases, and the initial staging, restaging, therapy planning, and monitoring response of lung cancer
-
Mavi A, Lakhani P, Zhuang H, Gupta NC, Alavi A. Fluorodeoxyglucose-PET in characterizing solitary pulmonary nodules, assessing pleural diseases, and the initial staging, restaging, therapy planning, and monitoring response of lung cancer. Radiol Clin North Am 2005;43:1-21.
-
(2005)
Radiol. Clin. North Am.
, vol.43
, pp. 1-21
-
-
Mavi, A.1
Lakhani, P.2
Zhuang, H.3
Gupta, N.C.4
Alavi, A.5
-
8
-
-
26944500889
-
Utility of 18F-FDG PET in evaluating cancers of lung
-
Acker MR, Burrell SC. Utility of 18F-FDG PET in evaluating cancers of lung. J Nucl Med Technol 2005;33:69-74.
-
(2005)
J. Nucl Med. Technol.
, vol.33
, pp. 69-74
-
-
Acker, M.R.1
Burrell, S.C.2
-
9
-
-
0035197858
-
Imaging of lung cancer with CT, MRI and PET
-
Haberkorn U, Schoenberg SO. Imaging of lung cancer with CT, MRI and PET. Lung Cancer2001;34: S13-23.
-
(2001)
Lung Cancer
, vol.34
-
-
Haberkorn, U.1
Schoenberg, S.O.2
-
10
-
-
0035925107
-
Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: A meta-analysis
-
Gould MK, Maclean CC, Kuschner WG, Rydzak CE, Owens DK. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: A meta-analysis. JAMA2001;285:914-24.
-
(2001)
JAMA
, vol.285
, pp. 914-924
-
-
Gould, M.K.1
Maclean, C.C.2
Kuschner, W.G.3
Rydzak, C.E.4
Owens, D.K.5
-
11
-
-
58149391080
-
Noninvasive diagnosis of solitary pulmonary lesions in cancer patients based on 2-fluoro-2-deoxy-D-glucose avidity on positron emission tomography/computed tomography
-
Bar-Shalom R, Kagna O, Israel O, Guralnik L. Noninvasive diagnosis of solitary pulmonary lesions in cancer patients based on 2-fluoro-2-deoxy-D- glucose avidity on positron emission tomography/computed tomography. Cancer 2008;113:3213-21.
-
(2008)
Cancer
, vol.113
, pp. 3213-3221
-
-
Bar-Shalom, R.1
Kagna, O.2
Israel, O.3
Guralnik, L.4
-
12
-
-
38349098945
-
Impact of dual-timepoint (18) F-FDG PET imaging and partial volume correction in the assessment of solitary pulmonary nodules
-
Alkhawaldeh K, Bural G, Kumar R, Alavi A. Impact of dual-timepoint (18) F-FDG PET imaging and partial volume correction in the assessment of solitary pulmonary nodules. Eur J Nucl Med Mol Imaging 2008;35:246-52.
-
(2008)
Eur. J. Nucl Med. Mol. Imaging
, vol.35
, pp. 246-252
-
-
Alkhawaldeh, K.1
Bural, G.2
Kumar, R.3
Alavi, A.4
-
13
-
-
0031922162
-
Localized form of bronchioloalveolar carcinoma: FDG PET findings
-
Kim BT, Kim Y, Lee KS, Yoon SB, Cheon EM, Kwon OJ, et al. Localized form of bronchioloalveolar carcinoma: FDG PET findings. AJR Am J Roentgenol 1997;170:935-9.
-
(1997)
AJR Am. J. Roentgenol
, vol.170
, pp. 935-939
-
-
Kim, B.T.1
Kim, Y.2
Lee, K.S.3
Yoon, S.B.4
Cheon, E.M.5
Kwon, O.J.6
-
14
-
-
0031898490
-
Evaluation of primary pulmonary carcinoid tumors using positron emission tomography with 18F-fluorodeoxyglucose
-
Erasmus JJ, McAdams HP, Patz EF Jr, Coleman RE, Ahuja V, Goodman PC. Evaluation of primary pulmonary carcinoid tumors using positron emission tomography with 18F-fluorodeoxyglucose. AJR Am J Roentgenol 1998;170:1369-73.
-
(1998)
AJR Am. J. Roentgenol
, vol.170
, pp. 1369-1373
-
-
Erasmus, J.J.1
McAdams, H.P.2
Patz Jr., E.F.3
Coleman, R.E.4
Ahuja, V.5
Goodman, P.C.6
-
15
-
-
0026090580
-
Imaging strategies in the staging of lung cancer
-
Webb WR, Golden JA. Imaging strategies in the staging of lung cancer. Clin Chest Med 1991;12:133-50.
-
(1991)
Clin. Chest Med.
, vol.12
, pp. 133-150
-
-
Webb, W.R.1
Golden, J.A.2
-
17
-
-
0023617149
-
A prospective evaluation of magnetic resonance imaging, computed tomography, and mediastinoscopy in the preoperative assessment of mediastinal node status in bronchogenic carcinoma
-
Patterson GA, Ginsberg RJ, Poon PY, Cooper JD, Goldberg M, Jones D, et al. A prospective evaluation of magnetic resonance imaging, computed tomography, and mediastinoscopy in the preoperative assessment of mediastinal node status in bronchogenic carcinoma. J Thorac Cardiovasc Surg 1987;94:679-84.
-
(1987)
J. Thorac. Cardiovasc. Surg.
, vol.94
, pp. 679-684
-
-
Patterson, G.A.1
Ginsberg, R.J.2
Poon, P.Y.3
Cooper, J.D.4
Goldberg, M.5
Jones, D.6
-
18
-
-
0034125297
-
FDG PET of pleural effusions in patients with non-small cell lung cancer
-
Erasmus JJ, McAdams HP, Rossi SE, Goodman PC, Coleman RE, Patz EF. FDG PET of pleural effusions in patients with non-small cell lung cancer. AJR Am J Roentgenol 2000;175:245-9.
-
(2000)
AJR Am. J. Roentgenol
, vol.175
, pp. 245-249
-
-
Erasmus, J.J.1
McAdams, H.P.2
Rossi, S.E.3
Goodman, P.C.4
Coleman, R.E.5
Patz, E.F.6
-
19
-
-
0036930012
-
Clinical role of F-18 fluorodeoxyglucose positron emission tomography imaging in patients with lung cancer and suspected malignant pleural effusion
-
Gupta NC, Rogers JS, Graeber GM, Gregory JL, Waheed U, Mullet D, et al. Clinical role of F-18 fluorodeoxyglucose positron emission tomography imaging in patients with lung cancer and suspected malignant pleural effusion. Chest 2002;122:1918-24.
-
(2002)
Chest
, vol.122
, pp. 1918-1924
-
-
Gupta, N.C.1
Rogers, J.S.2
Graeber, G.M.3
Gregory, J.L.4
Waheed, U.5
Mullet, D.6
-
20
-
-
13244296615
-
PET/CT using 18F-FDG in suspected lung cancer recurrence: Diagnostic value and impact on patient management
-
Keidar Z, Haim N, Guralnik L, Wollner M, Bar-Shalom R, Ben-Nun A, et al. PET/CT using 18F-FDG in suspected lung cancer recurrence: Diagnostic value and impact on patient management. J Nucl Med 2004;45:1640-6.
-
(2004)
J. Nucl Med.
, vol.45
, pp. 1640-1646
-
-
Keidar, Z.1
Haim, N.2
Guralnik, L.3
Wollner, M.4
Bar-Shalom, R.5
Ben-Nun, A.6
-
21
-
-
4444346932
-
The accuracy of integrated PET-CT compared with dedicated PEt alone for the staging of patients with nonsmall cell lung cancer
-
Cerfolio RJ, Ojha B, Bryant AS, Raghuveer V, Mountz JM, Bartolucci AA. The accuracy of integrated PET-CT compared with dedicated PEt alone for the staging of patients with nonsmall cell lung cancer. Ann Thorac Surg 2004;78:1017-23.
-
(2004)
Ann. Thorac. Surg.
, vol.78
, pp. 1017-1023
-
-
Cerfolio, R.J.1
Ojha, B.2
Bryant, A.S.3
Raghuveer, V.4
Mountz, J.M.5
Bartolucci, A.A.6
-
22
-
-
0037792992
-
Staging of non-small cell lung cancer with integrated positronemission tomography and computed tomography
-
Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, et al. Staging of non-small cell lung cancer with integrated positronemission tomography and computed tomography. N Engl J Med 2003;348:2500-7.
-
(2003)
N Engl. J. Med.
, vol.348
, pp. 2500-2507
-
-
Lardinois, D.1
Weder, W.2
Hany, T.F.3
Kamel, E.M.4
Korom, S.5
Seifert, B.6
-
23
-
-
16644393039
-
18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer
-
Kumar R, Xiu Y, Yu JQ, Takalkar A, El-Haddad G, Potenta S, et al. 18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer. J Nucl Med 2004;45:2058-62.
-
(2004)
J. Nucl Med.
, vol.45
, pp. 2058-2062
-
-
Kumar, R.1
Xiu, Y.2
Yu, J.Q.3
Takalkar, A.4
El-Haddad, G.5
Potenta, S.6
-
24
-
-
0031137948
-
Positron emission tomography, bronchogenic carcinoma, and the adrenals
-
Lamki LM. Positron emission tomography, bronchogenic carcinoma, and the adrenals. AJR Am J Roentgenol 1997;168:1361-2.
-
(1997)
AJR Am. J. Roentgenol
, vol.168
, pp. 1361-1362
-
-
Lamki, L.M.1
-
25
-
-
68549140265
-
Early prediction of response to first-line therapy using integrated 18F-FDG PET/CT for patients with advanced/metastatic non-small cell lung cancer
-
Lee DH, Kim SK, Lee HY, Lee SY, Park SH, Kim HY, et al. Early prediction of response to first-line therapy using integrated 18F-FDG PET/CT for patients with advanced/metastatic non-small cell lung cancer. J Thorac Oncol 2009;4:816-21.
-
(2009)
J. Thorac. Oncol.
, vol.4
, pp. 816-821
-
-
Lee, D.H.1
Kim, S.K.2
Lee, H.Y.3
Lee, S.Y.4
Park, S.H.5
Kim, H.Y.6
-
26
-
-
34250678597
-
Time course of early response to chemotherapy in non-small cell lung cancer patients with 18F-FDG PET/CT
-
Nahmias C, Hanna WT, Wahl LM, Long MJ, Hubner KF, Townsend DW. Time course of early response to chemotherapy in non-small cell lung cancer patients with 18F-FDG PET/CT. J Nucl Med 2007;48:744-51.
-
(2007)
J. Nucl Med.
, vol.48
, pp. 744-751
-
-
Nahmias, C.1
Hanna, W.T.2
Wahl, L.M.3
Long, M.J.4
Hubner, K.F.5
Townsend, D.W.6
-
27
-
-
6344292582
-
Accuracy and cost-effectiveness of [18F]-2-fluoro-deoxy-D-glucose- positron emission tomography scan in potentially resectable non-small cell lung cancer
-
Kelly RF, Tran T, Holmstrom A, Murar J, Segurola RJ Jr. Accuracy and cost-effectiveness of [18F]-2-fluoro-deoxy-D-glucose-positron emission tomography scan in potentially resectable non-small cell lung cancer. Chest 2004;125:1413-23.
-
(2004)
Chest
, vol.125
, pp. 1413-1423
-
-
Kelly, R.F.1
Tran, T.2
Holmstrom, A.3
Murar, J.4
Segurola Jr., R.J.5
-
28
-
-
40449093361
-
Recommendations on the use of 18F-FDG PET in oncology
-
Fletcher JW, Djulbegovic B, Soares HP, Siegel BA, Lowe VJ, Lyman GH, et al. Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med 2008;49:480-508.
-
(2008)
J. Nucl Med.
, vol.49
, pp. 480-508
-
-
Fletcher, J.W.1
Djulbegovic, B.2
Soares, H.P.3
Siegel, B.A.4
Lowe, V.J.5
Lyman, G.H.6
-
29
-
-
45049083558
-
The use of 18F-FDG PET/CT in colorectal liver metastases-comparison with CT and liver MRI
-
Kong G, Jackson C, Koh DM, Lewington V, Sharma B, Brown G, et al. The use of 18F-FDG PET/CT in colorectal liver metastases-comparison with CT and liver MRI. Eur J Nucl Med Mol Imaging 2008;35:1323-9.
-
(2008)
Eur. J. Nucl Med. Mol. Imaging
, vol.35
, pp. 1323-1329
-
-
Kong, G.1
Jackson, C.2
Koh, D.M.3
Lewington, V.4
Sharma, B.5
Brown, G.6
-
30
-
-
34748814336
-
Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy
-
Capirci C, Rampin L, Erba PA, Galeotti F, Crepaldi G, Banti E, et al. Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy. Eur J Nucl Med Mol Imaging 2007;34:1583-93.
-
(2007)
Eur. J. Nucl Med. Mol. Imaging
, vol.34
, pp. 1583-1593
-
-
Capirci, C.1
Rampin, L.2
Erba, P.A.3
Galeotti, F.4
Crepaldi, G.5
Banti, E.6
-
31
-
-
0033925753
-
A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer
-
Huebner RH, Park KC, Shepherd JE, Schwimmer J, Czernin J, Phelps ME, et al. A meta-analysis of the literature for whole-body FDG PET detection of colorectal cancer. J Nucl Med 2000;41:1177-89. (Pubitemid 30464000)
-
(2000)
Journal of Nuclear Medicine
, vol.41
, Issue.7
, pp. 1177-1189
-
-
Huebner, R.H.1
Park, K.C.2
Shepherd, J.E.3
Schwimmer, J.4
Czernin, J.5
Phelps, M.E.6
Gambhir, S.S.7
-
32
-
-
10044237741
-
Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver?
-
Selzner M, Hany TF, Wildbrett P, McCormack L, Kadry Z, Clavien PA. Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg 2004;240:1027-36.
-
(2004)
Ann. Surg.
, vol.240
, pp. 1027-1036
-
-
Selzner, M.1
Hany, T.F.2
Wildbrett, P.3
McCormack, L.4
Kadry, Z.5
Clavien, P.A.6
-
33
-
-
0031787451
-
Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: Review of 183, 134 screening mammograms in Albuquerque, New Mexico
-
Rosenberg RD, Hunt WC, Williamson MR, Gilliland FD, Wiest PW, Kelsey CA, et al. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: Review of 183, 134 screening mammograms in Albuquerque, New Mexico. Radiology 1998;209:511-8.
-
(1998)
Radiology
, vol.209
, pp. 511-518
-
-
Rosenberg, R.D.1
Hunt, W.C.2
Williamson, M.R.3
Gilliland, F.D.4
Wiest, P.W.5
Kelsey, C.A.6
-
34
-
-
0036787397
-
Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: An analysis of 27, 825 patient evaluations
-
Kolb TM, Lichy J, Newhouse JH. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: An analysis of 27, 825 patient evaluations. Radiology 2002;225:165-75.
-
(2002)
Radiology
, vol.225
, pp. 165-175
-
-
Kolb, T.M.1
Lichy, J.2
Newhouse, J.H.3
-
35
-
-
5444234387
-
Fluorodeoxyglucose-PET in the management of breast cancer
-
Kumar R, Alavi A. Fluorodeoxyglucose-PET in the management of breast cancer. Radiol Clin North Am 2004;42:1113-22.
-
(2004)
Radiol. Clin. North Am.
, vol.42
, pp. 1113-1122
-
-
Kumar, R.1
Alavi, A.2
-
36
-
-
33751017052
-
Stanadarized upatke value in normal breast: Effect of age, density and menopausal status
-
Kumar R, Chauhan A, Zhuang H, Chandra P, Schnall M, Alavi A. Stanadarized upatke value in normal breast: Effect of age, density and menopausal status. Mol Imaging Biol 2006;8:355-62.
-
(2006)
Mol. Imaging Biol.
, vol.8
, pp. 355-362
-
-
Kumar, R.1
Chauhan, A.2
Zhuang, H.3
Chandra, P.4
Schnall, M.5
Alavi, A.6
-
37
-
-
12344276012
-
A prospective evaluation of positron emission tomography scanning, sentinel lymph node biopsy, and standard axillary dissection for axillary staging in patients with early stage breast cancer
-
Lovrics PJ, Chen V, Coates G, Cornacchi SD, Goldsmith CH, Law C, et al. A prospective evaluation of positron emission tomography scanning, sentinel lymph node biopsy, and standard axillary dissection for axillary staging in patients with early stage breast cancer. Ann Surg Oncol 2004;11:846-53.
-
(2004)
Ann. Surg. Oncol.
, vol.11
, pp. 846-853
-
-
Lovrics, P.J.1
Chen, V.2
Coates, G.3
Cornacchi, S.D.4
Goldsmith, C.H.5
Law, C.6
-
38
-
-
33645963359
-
FDG-PET positive lymph nodes are highly predictive of metastasis in breast cancer
-
Kumar R, Zhuang H, Schnall M, Conant E, Damia S, Weinstein S, et al. FDG-PET positive lymph nodes are highly predictive of metastasis in breast cancer. Nucl Med Commun 2006;27:231-6.
-
(2006)
Nucl Med. Commun.
, vol.27
, pp. 231-236
-
-
Kumar, R.1
Zhuang, H.2
Schnall, M.3
Conant, E.4
Damia, S.5
Weinstein, S.6
-
39
-
-
48749083122
-
Breast cancer staging in a single session: Wholebody PET/CT mammography
-
Heusner TA, Kuemmel S, Umutlu L, Koeninger A, Freudenberg LS, Hauth EA, et al. Breast cancer staging in a single session: Wholebody PET/CT mammography. J Nucl Med 2008;49:1215-22.
-
(2008)
J. Nucl Med.
, vol.49
, pp. 1215-1222
-
-
Heusner, T.A.1
Kuemmel, S.2
Umutlu, L.3
Koeninger, A.4
Freudenberg, L.S.5
Hauth, E.A.6
-
40
-
-
0034001789
-
Positron emission tomography using [(18) F]fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer
-
Schelling M, Avril N, Nährig J, Kuhn W, Römer W, Sattler D, et al. Positron emission tomography using [(18) F]fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer. J Clin Oncol 2000;18:1689-95.
-
(2000)
J. Clin. Oncol.
, vol.18
, pp. 1689-1695
-
-
Schelling, M.1
Avril, N.2
Nährig, J.3
Kuhn, W.4
Römer, W.5
Sattler, D.6
-
41
-
-
0034002488
-
Positron emission tomography using [(18) F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy
-
Smith IC, Welch AE, Hutcheon AW, Miller ID, Payne S, Chilcott F, et al. Positron emission tomography using [(18) F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy. J Clin Oncol 2000;18:1676-88.
-
(2000)
J. Clin. Oncol.
, vol.18
, pp. 1676-1688
-
-
Smith, I.C.1
Welch, A.E.2
Hutcheon, A.W.3
Miller, I.D.4
Payne, S.5
Chilcott, F.6
-
42
-
-
67349209897
-
Role of 18F-FDG PET-CT in evaluation of early response to neoadjuvant chemotherapy in patients with locally advanced breast cancer
-
Kumar A, Kumar R, Seenu V, Gupta SD, Chawla M, Malhotra A, et al. Role of 18F-FDG PET-CT in evaluation of early response to neoadjuvant chemotherapy in patients with locally advanced breast cancer. Eur Radiol 2009;19:1347-57.
-
(2009)
Eur. Radiol.
, vol.19
, pp. 1347-1357
-
-
Kumar, A.1
Kumar, R.2
Seenu, V.3
Gupta, S.D.4
Chawla, M.5
Malhotra, A.6
-
43
-
-
0035991797
-
Use of serial FDG PET to measure the response of bonedominant breast cancer to therapy
-
Stafford SE, Gralow JR, Schubert EK, Rinn KJ, Dunnwald LK, Livingston RB, et al. Use of serial FDG PET to measure the response of bonedominant breast cancer to therapy. Acad Radiol 2002;9:913-21.
-
(2002)
Acad. Radiol.
, vol.9
, pp. 913-921
-
-
Stafford, S.E.1
Gralow, J.R.2
Schubert, E.K.3
Rinn, K.J.4
Dunnwald, L.K.5
Livingston, R.B.6
-
44
-
-
0034926124
-
Current status of breast cancer imaging, staging and therapy
-
Wahl RL. Current status of breast cancer imaging, staging and therapy. Semin Roentgenol 2001;36:250-60.
-
(2001)
Semin Roentgenol
, vol.36
, pp. 250-260
-
-
Wahl, R.L.1
-
45
-
-
76349120360
-
Integrated contrast-enhanced diagnostic whole-body PET/CT as a first-line restaging modality in patients with suspected metastatic recurrence of breast cancer
-
Dirisamer A, Halpern BS, Flöry D, Wolf F, Beheshti M, Mayerhoefer ME, et al. Integrated contrast-enhanced diagnostic whole-body PET/CT as a first-line restaging modality in patients with suspected metastatic recurrence of breast cancer. Eur J Radiol 2010;73:294-9.
-
(2010)
Eur. J. Radiol.
, vol.73
, pp. 294-299
-
-
Dirisamer, A.1
Halpern, B.S.2
Flöry, D.3
Wolf, F.4
Beheshti, M.5
Mayerhoefer, M.E.6
-
46
-
-
0036369753
-
Detection of locoregional and distant recurrences in breast cancer patients by using FDG PET
-
Eubank WB, Mankoff DA, Vesselle HJ, Eary JF, Schubert EK, Dunnwald LK, et al. Detection of locoregional and distant recurrences in breast cancer patients by using FDG PET. Radiographics 2002;22:5-17.
-
(2002)
Radiographics
, vol.22
, pp. 5-17
-
-
Eubank, W.B.1
Mankoff, D.A.2
Vesselle, H.J.3
Eary, J.F.4
Schubert, E.K.5
Dunnwald, L.K.6
-
47
-
-
45549090622
-
Comparison of gallium and PET scans at diagnosis and followup of pediatric patients with Hodgkin lymphoma
-
Hines-Thomas M, Kaste SC, Hudson MM, Howard SC, Liu WA, Wu J, et al. Comparison of gallium and PET scans at diagnosis and followup of pediatric patients with Hodgkin lymphoma. Pediatr Blood Cancer 2008;51:198-203.
-
(2008)
Pediatr. Blood Cancer
, vol.51
, pp. 198-203
-
-
Hines-Thomas, M.1
Kaste, S.C.2
Hudson, M.M.3
Howard, S.C.4
Liu, W.A.5
Wu, J.6
-
48
-
-
5444248062
-
Utility of fluorodeoxyglucose-PET imaging in the management of patients with Hodgkin's and non-Hodgkin's lymphomas
-
Kumar R, Maillard I, Schuster SJ, Alavi A. Utility of fluorodeoxyglucose-PET imaging in the management of patients with Hodgkin's and non-Hodgkin's lymphomas. Radiol Clin North Am 2004;42:1083-100.
-
(2004)
Radiol. Clin. North Am.
, vol.42
, pp. 1083-1100
-
-
Kumar, R.1
Maillard, I.2
Schuster, S.J.3
Alavi, A.4
-
49
-
-
48349111946
-
Role of whole-body [18F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) and conventional techniques in the staging of patients with hodgkin and aggressive non hodgkin lymphoma
-
Pelosi E, Pregno P, Penna D, Deandreis D, Chiappella A, Limerutti G, et al. Role of whole-body [18F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) and conventional techniques in the staging of patients with Hodgkin and aggressive non Hodgkin lymphoma. Radiol Med 2008;113:578-90.
-
(2008)
Radiol. Med.
, vol.113
, pp. 578-590
-
-
Pelosi, E.1
Pregno, P.2
Penna, D.3
Deandreis, D.4
Chiappella, A.5
Limerutti, G.6
-
50
-
-
48149107175
-
FDG avidity and PET/CT patterns in primary gastric lymphoma
-
Radan L, Fischer D, Bar-Shalom R, Dann EJ, Epelbaum R, Haim N, et al. FDG avidity and PET/CT patterns in primary gastric lymphoma. Eur J Nucl Med Mol Imaging 2008;35:1424-30.
-
(2008)
Eur. J. Nucl Med. Mol. Imaging
, vol.35
, pp. 1424-1430
-
-
Radan, L.1
Fischer, D.2
Bar-Shalom, R.3
Dann, E.J.4
Epelbaum, R.5
Haim, N.6
-
51
-
-
71049176527
-
Bone and [(18) F]Fluorodeoxyglucose positron-emission tomography/computed tomography scanning for the assessment of osseous involvement in Hodgkin lymphoma in children and young adults
-
Shulkin BL, Goodin GS, McCarville MB, Kaste SC, Krasin MJ, Hudson MM, et al. Bone and [(18) F]Fluorodeoxyglucose positron-emission tomography/computed tomography scanning for the assessment of osseous involvement in Hodgkin lymphoma in children and young adults. Leuk Lymphoma 2009;50:1794-802.
-
(2009)
Leuk Lymphoma
, vol.50
, pp. 1794-1802
-
-
Shulkin, B.L.1
Goodin, G.S.2
McCarville, M.B.3
Kaste, S.C.4
Krasin, M.J.5
Hudson, M.M.6
-
52
-
-
16544394931
-
FDG-PET in evaluation of treatment response in patients with gastrointestinal tract lymphomas
-
Kumar R, Xiu Y, Potenta S, Mavi A, Zhuang H, Yu JQ, et al. FDG-PET in evaluation of treatment response in patients with gastrointestinal tract lymphomas. J Nucl Med 2004;45:1796-803.
-
(2004)
J. Nucl Med.
, vol.45
, pp. 1796-1803
-
-
Kumar, R.1
Xiu, Y.2
Potenta, S.3
Mavi, A.4
Zhuang, H.5
Yu, J.Q.6
-
53
-
-
34748853773
-
Therapeutic evaluation and prognostic value of interim hybrid PET/CT with (18) F-FDG after three to four cycles of chemotherapy in non-Hodgkin's lymphoma
-
Zhao J, Qiao W, Wang C, Wang T, Xing Y. Therapeutic evaluation and prognostic value of interim hybrid PET/CT with (18) F-FDG after three to four cycles of chemotherapy in non-Hodgkin's lymphoma. Hematology 2007;12:423-30.
-
(2007)
Hematology
, vol.12
, pp. 423-430
-
-
Zhao, J.1
Qiao, W.2
Wang, C.3
Wang, T.4
Xing, Y.5
-
54
-
-
39449102141
-
The prognostic value of 18F-FDG PET-CT in the management of Hodgkin's lymphoma: Preliminary results of a prospective study
-
Paolini R, Rampin L, Rodella E, Ramazzina E, Banti E, Al-Nahhas A, et al. The prognostic value of 18F-FDG PET-CT in the management of Hodgkin's lymphoma: Preliminary results of a prospective study. Nucl Med Rev Cent East Eur 2007;10:87-90.
-
(2007)
Nucl Med. Rev. Cent East Eur.
, vol.10
, pp. 87-90
-
-
Paolini, R.1
Rampin, L.2
Rodella, E.3
Ramazzina, E.4
Banti, E.5
Al-Nahhas, A.6
-
55
-
-
0141669363
-
Clinical performance of PET-CT in evaluation of cancer. Additional value for diagnostic imaging and patient management
-
Bar-Shalom R, Yefremov N, Guralnik L, Gaitini D, Frenkel A, Kuten A, et al. Clinical performance of PET-CT in evaluation of cancer. Additional value for diagnostic imaging and patient management. J Nucl Med 2003;44:1200-9.
-
(2003)
J. Nucl Med.
, vol.44
, pp. 1200-1209
-
-
Bar-Shalom, R.1
Yefremov, N.2
Guralnik, L.3
Gaitini, D.4
Frenkel, A.5
Kuten, A.6
-
56
-
-
18644386584
-
Dual modality of 18F-fluorodeoxyglucosepositron emission tomography/computed tomography in patients with cervical carcinoma of unknown primary
-
Freudenberg LS, Fischer M, Antoch G, Jentzen W, Gutzeit A, Rosenbaum SJ, et al. Dual modality of 18F-fluorodeoxyglucosepositron emission tomography/computed tomography in patients with cervical carcinoma of unknown primary. Med Princ Pract 2005;14:155-60.
-
(2005)
Med. Princ Pract.
, vol.14
, pp. 155-160
-
-
Freudenberg, L.S.1
Fischer, M.2
Antoch, G.3
Jentzen, W.4
Gutzeit, A.5
Rosenbaum, S.J.6
-
57
-
-
33847363932
-
Use of integrated 18F-FDG PET/CT to improve the accuracy of initial cervical nodal evaluation in patients with head and neck squamous cell carcinoma
-
Jeong HS, Baek CH, Son YI, Ki Chung M, Kyung Lee D, Young Choi J, et al. Use of integrated 18F-FDG PET/CT to improve the accuracy of initial cervical nodal evaluation in patients with head and neck squamous cell carcinoma. Head Neck 2007;29:203-10.
-
(2007)
Head Neck
, vol.29
, pp. 203-210
-
-
Jeong, H.S.1
Baek, C.H.2
Son, Y.I.3
Chung, M.K.4
Lee, D.K.5
Choi, J.Y.6
-
58
-
-
1642275593
-
Head and neck cancer: Clinical usefulness and accuracy of PET/CT image fusion
-
Schöder H, Yeung HW, Gonen M, Kraus D, Larson SM. Head and neck cancer: Clinical usefulness and accuracy of PET/CT image fusion. Radiology 2004;231:65-72.
-
(2004)
Radiology
, vol.231
, pp. 65-72
-
-
Schöder, H.1
Yeung, H.W.2
Gonen, M.3
Kraus, D.4
Larson, S.M.5
-
59
-
-
33748543570
-
Post treatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers
-
Andrade RS, Heron DE, Degirmenci B, Filho PA, Branstetter BF, Seethala RR, et al. Post treatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers. Int J Radiat Oncol Biol Phys 2006;65:1315-22.
-
(2006)
Int. J. Radiat. Oncol. Biol. Phys.
, vol.65
, pp. 1315-1322
-
-
Andrade, R.S.1
Heron, D.E.2
Degirmenci, B.3
Filho, P.A.4
Branstetter, B.F.5
Seethala, R.R.6
-
60
-
-
36749001499
-
Clinical impact of and prognostic stratification by, F-18 FDG PET/CT in head and neck mucosal squamous cell carcinoma
-
Connell CA, Corry J, Milner AD, Hogg A, Hicks RJ, Rischin D, et al. Clinical impact of and prognostic stratification by, F-18 FDG PET/CT in head and neck mucosal squamous cell carcinoma. Head Neck 2007;29:986-95.
-
(2007)
Head Neck
, vol.29
, pp. 986-995
-
-
Connell, C.A.1
Corry, J.2
Milner, A.D.3
Hogg, A.4
Hicks, R.J.5
Rischin, D.6
-
61
-
-
61449256606
-
Evaluation of thyroid FDG uptake incidentally identified on FDG-PET/CT imaging
-
Chen W, Parsons M, Torigian DA, Zhuang H, Alavi A. Evaluation of thyroid FDG uptake incidentally identified on FDG-PET/CT imaging. Nucl Med Commun 2009;30:240-4.
-
(2009)
Nucl Med. Commun.
, vol.30
, pp. 240-244
-
-
Chen, W.1
Parsons, M.2
Torigian, D.A.3
Zhuang, H.4
Alavi, A.5
-
62
-
-
68349111689
-
Value of 18F-FDG-PET/PET-CT in differentiated thyroid carcinoma with radioiodine-negative whole-body scan: A meta-analysis
-
Dong MJ, Liu ZF, Zhao K, Ruan LX, Wang GL, Yang SY, et al. Value of 18F-FDG-PET/PET-CT in differentiated thyroid carcinoma with radioiodine-negative whole-body scan: A meta-analysis. Nucl Med Commun 2009;30:639-50.
-
(2009)
Nucl Med. Commun.
, vol.30
, pp. 639-650
-
-
Dong, M.J.1
Liu, Z.F.2
Zhao, K.3
Ruan, L.X.4
Wang, G.L.5
Yang, S.Y.6
-
63
-
-
13444301390
-
The role of positron emission tomography/computed tomography in the management of recurrent papillary thyroid carcinoma
-
Nahas Z, Goldenberg D, Fakhry C, Ewertz M, Zeiger M, Ladenson PW, et al. The role of positron emission tomography/computed tomography in the management of recurrent papillary thyroid carcinoma. Laryngoscope 2005;115:237-43.
-
(2005)
Laryngoscope
, vol.115
, pp. 237-243
-
-
Nahas, Z.1
Goldenberg, D.2
Fakhry, C.3
Ewertz, M.4
Zeiger, M.5
Ladenson, P.W.6
-
65
-
-
0034746433
-
18F-DOPA positron emission tomography for tumor detection in patients with medullary thyroid carcinoma and elevated calcitonin levels
-
Hoegerle S, Altehoefer C, Ghanem N, Brink I, Moser E, Nitzsche E. 18F-DOPA positron emission tomography for tumor detection in patients with medullary thyroid carcinoma and elevated calcitonin levels. Eur J Nucl Med 2001;28:64-71.
-
(2001)
Eur. J. Nucl Med.
, vol.28
, pp. 64-71
-
-
Hoegerle, S.1
Altehoefer, C.2
Ghanem, N.3
Brink, I.4
Moser, E.5
Nitzsche, E.6
-
66
-
-
20044363992
-
FDG-PET/CT-guided intensity modulated head and neck radiotherapy: A pilot investigation
-
Schwartz DL, Ford EC, Rajendran J, Yueh B, Coltrera MD, Virgin J, et al. FDG-PET/CT-guided intensity modulated head and neck radiotherapy: A pilot investigation. Head Neck 2005;27:478-87.
-
(2005)
Head Neck
, vol.27
, pp. 478-487
-
-
Schwartz, D.L.1
Ford, E.C.2
Rajendran, J.3
Yueh, B.4
Coltrera, M.D.5
Virgin, J.6
-
67
-
-
17144373700
-
Clinical applications of fluorodeoxyglucose-positron emission tomography in the management of malignant melanoma
-
Kumar R, Alavi A. Clinical applications of fluorodeoxyglucose-positron emission tomography in the management of malignant melanoma. Curr Opin Oncol 2005;17:154-9.
-
(2005)
Curr. Opin. Oncol.
, vol.17
, pp. 154-159
-
-
Kumar, R.1
Alavi, A.2
-
68
-
-
42449144847
-
Routine positron emission tomography and positron emission tomography/computed tomography in melanoma staging with positive sentinel node biopsy is of limited benefit
-
Constantinidou A, Hofman M, O'Doherty M, Acland KM, Healy C, Harries M. Routine positron emission tomography and positron emission tomography/computed tomography in melanoma staging with positive sentinel node biopsy is of limited benefit. Melanoma Res 2008;18:56-60.
-
(2008)
Melanoma Res.
, vol.18
, pp. 56-60
-
-
Constantinidou, A.1
Hofman, M.2
O'Doherty, M.3
Acland, K.M.4
Healy, C.5
Harries, M.6
-
69
-
-
53549107743
-
Preoperative 18F-FDG-PET/CT imaging and sentinel node biopsy in the detection of regional lymph node metastases in malignant melanoma
-
Singh B, Ezziddin S, Palmedo H, Reinhardt M, Strunk H, Tüting T, et al. Preoperative 18F-FDG-PET/CT imaging and sentinel node biopsy in the detection of regional lymph node metastases in malignant melanoma. Melanoma Res 2008;18:346-52.
-
(2008)
Melanoma Res.
, vol.18
, pp. 346-352
-
-
Singh, B.1
Ezziddin, S.2
Palmedo, H.3
Reinhardt, M.4
Strunk, H.5
Tüting, T.6
-
71
-
-
0034284334
-
Positron emission tomography scanning in malignant melanoma: Clinical utility in patients with stage III disease
-
Tyler DS, Onaitis M, Kherani A, Hata A, Nicholson E, Keogan M, et al. Positron emission tomography scanning in malignant melanoma: Clinical utility in patients with stage III disease. Cancer 2000;89:1019-25.
-
(2000)
Cancer
, vol.89
, pp. 1019-1025
-
-
Tyler, D.S.1
Onaitis, M.2
Kherani, A.3
Hata, A.4
Nicholson, E.5
Keogan, M.6
-
72
-
-
33846019273
-
2-Deoxy-2-[F-18]fluoro-D-glucose positron emission tomography/computed tomography in the management of melanoma
-
Iagaru A, Quon A, Johnson D, Gambhir SS, McDougall IR. 2-Deoxy-2-[F-18]fluoro-D-glucose positron emission tomography/computed tomography in the management of melanoma. Mol Imaging Biol 2007;9:50-7.
-
(2007)
Mol. Imaging Biol.
, vol.9
, pp. 50-57
-
-
Iagaru, A.1
Quon, A.2
Johnson, D.3
Gambhir, S.S.4
McDougall, I.R.5
-
73
-
-
30544447307
-
Staging and follow-up of gastrointestinal tumors with PET/CT
-
Rosenbaum SJ, Stergar H, Antoch G, Veit P, Bockisch A, Kühl H. Staging and follow-up of gastrointestinal tumors with PET/CT. Abdom Imaging 2006;31:25-35.
-
(2006)
Abdom Imaging
, vol.31
, pp. 25-35
-
-
Rosenbaum, S.J.1
Stergar, H.2
Antoch, G.3
Veit, P.4
Bockisch, A.5
Kühl, H.6
-
74
-
-
20444417431
-
The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy
-
Cerfolio RJ, Bryant AS, Ohja B, Bartolucci AA, Eloubeidi MA. The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy. J Thorac Cardiovasc Surg 2005;129:1232-41.
-
(2005)
J. Thorac. Cardiovasc. Surg.
, vol.129
, pp. 1232-1241
-
-
Cerfolio, R.J.1
Bryant, A.S.2
Ohja, B.3
Bartolucci, A.A.4
Eloubeidi, M.A.5
-
75
-
-
0035136078
-
Evaluation of lymph node metastases in squamous cell carcinoma of the esophagus with positron emission tomography
-
Kim K, Park SJ, Kim BT, Lee KS, Shim YM. Evaluation of lymph node metastases in squamous cell carcinoma of the esophagus with positron emission tomography. Ann Thorac Surg 2001;71:290-4.
-
(2001)
Ann. Thorac. Surg.
, vol.71
, pp. 290-294
-
-
Kim, K.1
Park, S.J.2
Kim, B.T.3
Lee, K.S.4
Shim, Y.M.5
-
76
-
-
58149186740
-
Clinical role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in post-operative follow up of gastric cancer: Initial results
-
Sun L, Su XH, Guan YS, Pan WM, Luo ZM, Wei JH, et al. Clinical role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in post-operative follow up of gastric cancer: Initial results. World J Gastroenterol 2008;14:4627-32.
-
(2008)
World J. Gastroenterol.
, vol.14
, pp. 4627-4632
-
-
Sun, L.1
Su, X.H.2
Guan, Y.S.3
Pan, W.M.4
Luo, Z.M.5
Wei, J.H.6
-
78
-
-
77649127058
-
Non-invasive imaging surrogate of angiogenesis in osteosarcoma
-
Bajpai J, Gamanagatti S, Sharma MC, Kumar R, Vishnubhatla S, Khan SA, et al. Non-invasive imaging surrogate of angiogenesis in osteosarcoma. Pediatr Blood Cancer 2010;54:526-31.
-
(2010)
Pediatr. Blood Cancer
, vol.54
, pp. 526-531
-
-
Bajpai, J.1
Gamanagatti, S.2
Sharma, M.C.3
Kumar, R.4
Vishnubhatla, S.5
Khan, S.A.6
-
79
-
-
1242307295
-
The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; A systematic review and meta-analysis
-
Bastiaannet E, Groen H, Jager PL, Cobben DC, van der Graaf WT, Vaalburg W, et al. The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; A systematic review and meta-analysis. Cancer Treat Rev 2004;30:83-101.
-
(2004)
Cancer Treat Rev.
, vol.30
, pp. 83-101
-
-
Bastiaannet, E.1
Groen, H.2
Jager, P.L.3
Cobben, D.C.4
Van Der Graaf, W.T.5
Vaalburg, W.6
-
80
-
-
0031900784
-
Quantitative [F-18]fluorodeoxyglucose positron emission tomography in pretreatment and grading of sarcoma
-
Eary JF, Conrad EU, Bruckner JD, Folpe A, Hunt KJ, Mankoff DA, et al. Quantitative [F-18]fluorodeoxyglucose positron emission tomography in pretreatment and grading of sarcoma. Clin Cancer Res 1998;4:1215-20.
-
(1998)
Clin. Cancer Res.
, vol.4
, pp. 1215-1220
-
-
Eary, J.F.1
Conrad, E.U.2
Bruckner, J.D.3
Folpe, A.4
Hunt, K.J.5
Mankoff, D.A.6
-
81
-
-
0031745180
-
Evaluation of fluorodeoxyglucose positron emission tomography in the management of soft-tissue sarcomas
-
Lucas JD, O'Doherty MJ, Wong JC, Bingham JB, McKee PH, Fletcher CD, et al. Evaluation of fluorodeoxyglucose positron emission tomography in the management of soft-tissue sarcomas. J Bone Joint Surg Br.1998;80:441-447.
-
(1998)
J. Bone Joint Surg. Br.
, vol.80
, pp. 441-447
-
-
Lucas, J.D.1
O'Doherty, M.J.2
Wong, J.C.3
Bingham, J.B.4
McKee, P.H.5
Fletcher, C.D.6
-
82
-
-
0036948617
-
Diagnostic utility of FDG PET in multiple myeloma
-
Jadvar H, Conti PS. Diagnostic utility of FDG PET in multiple myeloma. Skeletal Radiol 2002;31:690-4.
-
(2002)
Skeletal Radiol.
, vol.31
, pp. 690-694
-
-
Jadvar, H.1
Conti, P.S.2
-
83
-
-
5444229070
-
PET imaging in gynecologic malignancies
-
Kumar R, Alavi A. PET imaging in gynecologic malignancies. Radiol Clin North Am 2004;42:1155-67.
-
(2004)
Radiol. Clin. North Am.
, vol.42
, pp. 1155-1167
-
-
Kumar, R.1
Alavi, A.2
-
84
-
-
33947218828
-
Role of [18F]FDG PET/CT in the assessment of suspected recurrent ovarian cancer: Correlation with clinical or histological findings
-
Chung HH, Kang WJ, Kim JW, Park NH, Song YS, Chung JK, et al. Role of [18F]FDG PET/CT in the assessment of suspected recurrent ovarian cancer: Correlation with clinical or histological findings. Eur J Nucl Med Mol Imaging 2007;34:480-6.
-
(2007)
Eur. J. Nucl. Med. Mol. Imaging
, vol.34
, pp. 480-486
-
-
Chung, H.H.1
Kang, W.J.2
Kim, J.W.3
Park, N.H.4
Song, Y.S.5
Chung, J.K.6
-
85
-
-
36649012843
-
Detection of recurrent ovarian cancer at MRI: Comparison with integrated PET/CT
-
Kim CK, Park BK, Choi JY, Kim BG, Han H. Detection of recurrent ovarian cancer at MRI: Comparison with integrated PET/CT. J Comput Assist Tomogr 2007;31:868-75.
-
(2007)
J. Comput Assist. Tomogr
, vol.31
, pp. 868-875
-
-
Kim, C.K.1
Park, B.K.2
Choi, J.Y.3
Kim, B.G.4
Han, H.5
-
86
-
-
0004931308
-
Avoiding second-look surgery and reducing costs in managing patients with ovarian cancer by applying F-18-FDG PET
-
Smith GT, Hubner KF, McDonald T, Thie JA. Avoiding second-look surgery and reducing costs in managing patients with ovarian cancer by applying F-18-FDG PET. Clin Positron Imaging1998;1:263.
-
(1998)
Clin. Positron Imaging
, vol.1
, pp. 263
-
-
Smith, G.T.1
Hubner, K.F.2
McDonald, T.3
Thie, J.A.4
-
87
-
-
34447571766
-
Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: Correlation with transvaginal ultrasonography, computed tomography, and histology
-
Castellucci P, Perrone AM, Picchio M, Ghi T, Farsad M, Nanni C, et al. Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: Correlation with transvaginal ultrasonography, computed tomography, and histology. Nucl Med Commun 2007;28:589-95.
-
(2007)
Nucl Med. Commun.
, vol.28
, pp. 589-595
-
-
Castellucci, P.1
Perrone, A.M.2
Picchio, M.3
Ghi, T.4
Farsad, M.5
Nanni, C.6
-
88
-
-
0027714787
-
Wholebody positron emission tomography with 2-[18F]-fluoro-2-deoxy-D- glucose can detect recurrent ovarian carcinoma
-
Karlan BY, Hawkins R, Hoh C, Lee M, Tse N, Cane P, et al. Wholebody positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose can detect recurrent ovarian carcinoma. Gynecol Oncol 1993;51:175-81.
-
(1993)
Gynecol. Oncol.
, vol.51
, pp. 175-181
-
-
Karlan, B.Y.1
Hawkins, R.2
Hoh, C.3
Lee, M.4
Tse, N.5
Cane, P.6
-
89
-
-
1642578792
-
PET-CT in recurrent ovarian cancer: Initial observations
-
Pannu HK, Bristow RE, Cohade C, Fishman EK, Wahl RL. et al. PET-CT in recurrent ovarian cancer: Initial observations. Radiographics 2004;24:209-23.
-
(2004)
Radiographics
, vol.24
, pp. 209-223
-
-
Pannu, H.K.1
Bristow, R.E.2
Cohade, C.3
Fishman, E.K.4
Wahl, R.L.5
-
90
-
-
0141974973
-
Clinically occult recurrent ovarian cancer: Patient selection for secondary cytoreductive surgery using combined PET/CT
-
Bristow RE, del Carmen MG, Pannu HK, Cohade C, Zahurak ML, Fishman EK, et al. Clinically occult recurrent ovarian cancer: Patient selection for secondary cytoreductive surgery using combined PET/CT. Gynecol Oncol 2003;90:519-28.
-
(2003)
Gynecol. Oncol.
, vol.90
, pp. 519-528
-
-
Bristow, R.E.1
Carmen, M.G.D.2
Pannu, H.K.3
Cohade, C.4
Zahurak, M.L.5
Fishman, E.K.6
-
91
-
-
50049120487
-
Role of PET/CT in the evaluation of cervical cancer
-
Jover R, Lourido D, Gonzalez C, Rojo A, Gorospe L, Alfonso JM. Role of PET/CT in the evaluation of cervical cancer. Gynecol Oncol2008;110: S55-9.
-
(2008)
Gynecol. Oncol.
, vol.110
-
-
Jover, R.1
Lourido, D.2
Gonzalez, C.3
Rojo, A.4
Gorospe, L.5
Alfonso, J.M.6
-
92
-
-
48649084362
-
The prognostic value of PET and PET/CT in cervical cancer
-
Grigsby PW. The prognostic value of PET and PET/CT in cervical cancer. Cancer Imaging 2008;8:146-55.
-
(2008)
Cancer Imaging
, vol.8
, pp. 146-155
-
-
Grigsby, P.W.1
-
93
-
-
67649392287
-
Imaging uterine cervical cancer with FDG-PET/CT: Direct comparison with PET
-
Tatsumi M, Cohade C, Bristow RE, Wahl RL. Imaging uterine cervical cancer with FDG-PET/CT: Direct comparison with PET. Mol Imaging Biol 2009;11:229-35.
-
(2009)
Mol. Imaging Biol.
, vol.11
, pp. 229-235
-
-
Tatsumi, M.1
Cohade, C.2
Bristow, R.E.3
Wahl, R.L.4
-
94
-
-
25144524980
-
Role of positron emission tomography in pretreatment lymph node staging of uterine cervical cancer: A prospective surgicopathologic correlation study
-
Roh JW, Seo SS, Lee S, Kang KW, Kim SK, Sim JS, et al. Role of positron emission tomography in pretreatment lymph node staging of uterine cervical cancer: A prospective surgicopathologic correlation study. Eur J Cancer 2005;41:2086-92.
-
(2005)
Eur. J. Cancer
, vol.41
, pp. 2086-2092
-
-
Roh, J.W.1
Seo, S.S.2
Lee, S.3
Kang, K.W.4
Kim, S.K.5
Sim, J.S.6
-
96
-
-
0642284541
-
Delayed (18) F-FDG PET for detection of paraaortic lymph node metastases in cervical cancer patients
-
Ma SY, See LC, Lai CH, Chou HH, Tsai CS, Ng KK, et al. Delayed (18) F-FDG PET for detection of paraaortic lymph node metastases in cervical cancer patients. J Nucl Med 2003;44:1775-83.
-
(2003)
J. Nucl Med.
, vol.44
, pp. 1775-1783
-
-
Ma, S.Y.1
See, L.C.2
Lai, C.H.3
Chou, H.H.4
Tsai, C.S.5
Ng, K.K.6
-
97
-
-
67650896451
-
Additional value of MR/PET fusion compared with PET/CT in the detection of lymph node metastases in cervical cancer patients
-
Kim SK, Choi HJ, Park SY, Lee HY, Seo SS, Yoo CW, et al. Additional value of MR/PET fusion compared with PET/CT in the detection of lymph node metastases in cervical cancer patients. Eur J Cancer 2009;45:2103-9.
-
(2009)
Eur. J. Cancer
, vol.45
, pp. 2103-2109
-
-
Kim, S.K.1
Choi, H.J.2
Park, S.Y.3
Lee, H.Y.4
Seo, S.S.5
Yoo, C.W.6
-
98
-
-
35048897536
-
18F-fluoro-2-deoxy-d-glucose-positron emission tomography (PET)/PET-computed tomography in carcinoma of the cervix
-
Kumar R, Dadparvar S. 18F-fluoro-2-deoxy-d-glucose-positron emission tomography (PET)/PET-computed tomography in carcinoma of the cervix. Cancer 2007;110:1650-3.
-
(2007)
Cancer
, vol.110
, pp. 1650-1653
-
-
Kumar, R.1
Dadparvar, S.2
-
99
-
-
63049136012
-
MRI and PET/CT for triaging stage IB clinically operable cervical cancer to appropriate therapy: Decision analysis to assess patient outcomes
-
Pandharipande PV, Choy G, del Carmen MG, Gazelle GS, Russell AH, Lee SI. MRI and PET/CT for triaging stage IB clinically operable cervical cancer to appropriate therapy: Decision analysis to assess patient outcomes. AJR Am J Roentgenol 2009;192:802-14.
-
(2009)
AJR Am. J. Roentgenol
, vol.192
, pp. 802-814
-
-
Pandharipande, P.V.1
Choy, G.2
Carmen, M.G.D.3
Gazelle, G.S.4
Russell, A.H.5
Lee, S.I.6
-
100
-
-
67349244271
-
Role of carbon-11 choline PET/CT in the management of uterine carcinoma: Initial experience
-
Sofue K, Tateishi U, Sawada M, Maeda T, Terauchi T, Kano D, et al. Role of carbon-11 choline PET/CT in the management of uterine carcinoma: Initial experience. Ann Nucl Med 2009;23:235-43.
-
(2009)
Ann. Nucl Med.
, vol.23
, pp. 235-243
-
-
Sofue, K.1
Tateishi, U.2
Sawada, M.3
Maeda, T.4
Terauchi, T.5
Kano, D.6
-
101
-
-
12844260883
-
Lack of benefit of concurrent chemotherapy in patients with cervical cancer and negative lymph nodes by FDG-PET
-
Grigsby PW, Mutch DG, Rader J, Herzog TJ, Zoberi I, Siegel BA, et al. Lack of benefit of concurrent chemotherapy in patients with cervical cancer and negative lymph nodes by FDG-PET. Int J Radiat Oncol Biol Phys 2005;61:444-49.
-
(2005)
Int. J. Radiat. Oncol. Biol. Phys.
, vol.61
, pp. 444-449
-
-
Grigsby, P.W.1
Mutch, D.G.2
Rader, J.3
Herzog, T.J.4
Zoberi, I.5
Siegel, B.A.6
-
102
-
-
1542346461
-
Treatment planning guidelines regarding the use of CT/PET-guided IMRT for cervical carcinoma with positive paraaortic lymph nodes
-
Esthappan J, Mutic S, Malyapa RS, Grigsby PW, Zoberi I, Dehdashti F, et al. Treatment planning guidelines regarding the use of CT/PET-guided IMRT for cervical carcinoma with positive paraaortic lymph nodes. Int J Radiat Oncol Biol Phys 2004;58:1289-97.
-
(2004)
Int. J. Radiat. Oncol. Biol. Phys.
, vol.58
, pp. 1289-1297
-
-
Esthappan, J.1
Mutic, S.2
Malyapa, R.S.3
Grigsby, P.W.4
Zoberi, I.5
Dehdashti, F.6
-
103
-
-
50049093501
-
PET/CT fusion scan enhances CT staging in patients with pancreatic neoplasms
-
Farma JM, Santillan AA, Melis M, Walters J, Belinc D, Chen DT, et al. PET/CT fusion scan enhances CT staging in patients with pancreatic neoplasms. Ann Surg Oncol 2008;15:2465-71.
-
(2008)
Ann. Surg. Oncol.
, vol.15
, pp. 2465-2471
-
-
Farma, J.M.1
Santillan, A.A.2
Melis, M.3
Walters, J.4
Belinc, D.5
Chen, D.T.6
-
104
-
-
51349115130
-
Contrast-enhanced 18F-FDG PET/CT: 1-stop-shop imaging for assessing the resectability of pancreatic cancer
-
Strobel K, Heinrich S, Bhure U, Soyka J, Veit-Haibach P, Pestalozzi BC, et al. Contrast-enhanced 18F-FDG PET/CT: 1-stop-shop imaging for assessing the resectability of pancreatic cancer. J Nucl Med 2008;49:1408-13.
-
(2008)
J. Nucl Med.
, vol.49
, pp. 1408-1413
-
-
Strobel, K.1
Heinrich, S.2
Bhure, U.3
Soyka, J.4
Veit-Haibach, P.5
Pestalozzi, B.C.6
-
105
-
-
77952658807
-
Usefulness of (18) F-FDG PET, combined FDG-PET/CT and EUS in diagnosing primary pancreatic carcinoma: A meta-analysis
-
Oct. 22. In press
-
Tang S, Huang G, Liu J, Liu T, Treven L, Song S, et al. Usefulness of (18) F-FDG PET, combined FDG-PET/CT and EUS in diagnosing primary pancreatic carcinoma: A meta-analysis. Eur J Radiol 2009 Oct. 22. [In press]
-
(2009)
Eur. J. Radiol.
-
-
Tang, S.1
Huang, G.2
Liu, J.3
Liu, T.4
Treven, L.5
Song, S.6
-
106
-
-
0036166730
-
Non-invasive differentiation of pancreatic lesions: Is analysis of FDG kinetics superior to semi quantitative uptake value analysis?
-
Nitzsche EU, Hoegerle S, Mix M, Brink I, Otte A, Moser E, et al. Non-invasive differentiation of pancreatic lesions: Is analysis of FDG kinetics superior to semi quantitative uptake value analysis? Eur J Nucl Med Mol Imaging 2002;29:237-42.
-
(2002)
Eur. J. Nucl Med. Mol. Imaging
, vol.29
, pp. 237-242
-
-
Nitzsche, E.U.1
Hoegerle, S.2
Mix, M.3
Brink, I.4
Otte, A.5
Moser, E.6
-
107
-
-
11144351693
-
F-18-fluorodeoxyglucose positron emission tomography in differentiating malignant from benign pancreatic cysts: A prospective study
-
Sperti C, Pasquali C, Decet G, Chierichetti F, Liessi G, Pedrazzoli S. F-18-fluorodeoxyglucose positron emission tomography in differentiating malignant from benign pancreatic cysts: A prospective study. J Gastrointest Surg 2005;9:22-8.
-
(2005)
J. Gastrointest Surg.
, vol.9
, pp. 22-28
-
-
Sperti, C.1
Pasquali, C.2
Decet, G.3
Chierichetti, F.4
Liessi, G.5
Pedrazzoli, S.6
-
108
-
-
22744437710
-
Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness
-
Heinrich S, Goerres GW, Schäfer M, Sagmeister M, Bauerfeind P, Pestalozzi BC, et al. Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness. Ann Surg 2005;242:235-43.
-
(2005)
Ann. Surg.
, vol.242
, pp. 235-243
-
-
Heinrich, S.1
Goerres, G.W.2
Schäfer, M.3
Sagmeister, M.4
Bauerfeind, P.5
Pestalozzi, B.C.6
-
109
-
-
43349099619
-
Initial evaluation of 18F-fluorothymidine (FLT) PET/CT scanning for primary pancreatic cancer
-
Quon A, Chang ST, Chin F, Kamaya A, Dick DW, Loo BW Jr, et al. Initial evaluation of 18F-fluorothymidine (FLT) PET/CT scanning for primary pancreatic cancer. Eur J Nucl Med Mol Imaging 2008;35:527-31.
-
(2008)
Eur. J. Nucl Med. Mol. Imaging
, vol.35
, pp. 527-531
-
-
Quon, A.1
Chang, S.T.2
Chin, F.3
Kamaya, A.4
Dick, D.W.5
Loo Jr., B.W.6
-
110
-
-
10744220310
-
Role of positron emission tomography with 2-deoxy-2-[18F]fluoro-D-glucose in evaluating the effects of arterial infusion chemotherapy and radiotherapy on pancreatic cancer
-
Yoshioka M, Sato T, Furuya T, Shibata S, Andoh H, Asanuma Y, et al. Role of positron emission tomography with 2-deoxy-2-[18F]fluoro-D-glucose in evaluating the effects of arterial infusion chemotherapy and radiotherapy on pancreatic cancer. J Gastroenterol 2004;39:50-5.
-
(2004)
J. Gastroenterol.
, vol.39
, pp. 50-55
-
-
Yoshioka, M.1
Sato, T.2
Furuya, T.3
Shibata, S.4
Andoh, H.5
Asanuma, Y.6
-
111
-
-
0032754122
-
Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma
-
Trojan J, Schroeder O, Raedle J, Baum RP, Herrmann G, Jacobi V, et al. Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma. Am J Gastroenterol 1999;94:3314-9.
-
(1999)
Am. J. Gastroenterol.
, vol.94
, pp. 3314-3319
-
-
Trojan, J.1
Schroeder, O.2
Raedle, J.3
Baum, R.P.4
Herrmann, G.5
Jacobi, V.6
-
112
-
-
70350482162
-
The clinical value of 18F-FDG PET/CT for investigating unexplained serum AFP elevation following interventional therapy for hepatocellular carcinom
-
Han AR, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, et al. The clinical value of 18F-FDG PET/CT for investigating unexplained serum AFP elevation following interventional therapy for hepatocellular carcinom. Hepatogastroenterology 2009;56:1111-6.
-
(2009)
Hepatogastroenterology
, vol.56
, pp. 1111-1116
-
-
Han, A.R.1
Gwak, G.Y.2
Choi, M.S.3
Lee, J.H.4
Koh, K.C.5
Paik, S.W.6
-
113
-
-
0034065863
-
Positron emission tomography scanning in the evaluation of hepatocellular carcinoma
-
Khan MA, Combs CS, Brunt EM, Lowe VJ, Wolverson MK, Solomon H, et al. Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. J Hepatol 2000;32:792-7.
-
(2000)
J. Hepatol.
, vol.32
, pp. 792-797
-
-
Khan, M.A.1
Combs, C.S.2
Brunt, E.M.3
Lowe, V.J.4
Wolverson, M.K.5
Solomon, H.6
-
114
-
-
35248882487
-
Positron emission tomography/computer tomography in guidance of extrahepatic hepatocellular carcinoma metastasis management
-
Sun L, Guan YS, Pan WM, Chen GB, Luo ZM, Wu H. Positron emission tomography/computer tomography in guidance of extrahepatic hepatocellular carcinoma metastasis management. World J Gastroenterol 2007;13:5413-5.
-
(2007)
World J. Gastroenterol.
, vol.13
, pp. 5413-5415
-
-
Sun, L.1
Guan, Y.S.2
Pan, W.M.3
Chen, G.B.4
Luo, Z.M.5
Wu, H.6
-
115
-
-
67349183386
-
Evaluation of patients with hepatocellular carcinomas using [(11) C]acetate and [(18) F]FDG PET/CT: A preliminary study
-
Hwang KH, Choi DJ, Lee SY, Lee MK, Choe W. Evaluation of patients with hepatocellular carcinomas using [(11) C]acetate and [(18) F]FDG PET/CT: A preliminary study. Appl Radiat Isot 2009;67:1195-8.
-
(2009)
Appl. Radiat. Isot
, vol.67
, pp. 1195-1198
-
-
Hwang, K.H.1
Choi, D.J.2
Lee, S.Y.3
Lee, M.K.4
Choe, W.5
-
116
-
-
57149101558
-
A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma
-
Park JW, Kim JH, Kim SK, Kang KW, Park KW, Choi JI, et al. A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma. J Nucl Med 2008;49:1912-21.
-
(2008)
J. Nucl Med.
, vol.49
, pp. 1912-1921
-
-
Park, J.W.1
Kim, J.H.2
Kim, S.K.3
Kang, K.W.4
Park, K.W.5
Choi, J.I.6
-
117
-
-
13844294023
-
The value of PET, CT and in-line PET/CT in patients with gastrointestinal stromal tumours: Long-term outcome of treatment with imatinib mesylate
-
Goerres GW, Stupp R, Barghouth G, Hany TF, Pestalozzi B, Dizendorf E, et al. The value of PET, CT and in-line PET/CT in patients with gastrointestinal stromal tumours: Long-term outcome of treatment with imatinib mesylate. Eur J Nucl Med Mol Imaging 2005;32:153-62.
-
(2005)
Eur. J. Nucl Med. Mol. Imaging
, vol.32
, pp. 153-162
-
-
Goerres, G.W.1
Stupp, R.2
Barghouth, G.3
Hany, T.F.4
Pestalozzi, B.5
Dizendorf, E.6
-
118
-
-
56749156278
-
FDG-PET and PET/CT in the clinical management of gastrointestinal stromal tumor
-
Basu S, Mohandas KM, Peshwe H, Asopa R, Vyawahare M. FDG-PET and PET/CT in the clinical management of gastrointestinal stromal tumor. Nucl Med Commun 2008;29:1026-39.
-
(2008)
Nucl Med. Commun.
, vol.29
, pp. 1026-1039
-
-
Basu, S.1
Mohandas, K.M.2
Peshwe, H.3
Asopa, R.4
Vyawahare, M.5
-
119
-
-
28244488664
-
(18) F-fluorodeoxyglucose positron emission tomography: Useful technique for predicting malignant potential of gastrointestinal stromal tumors
-
Kamiyama Y, Aihara R, Nakabayashi T, Mochiki E, Asao T, Kuwano H, et al. (18) F-Fluorodeoxyglucose Positron Emission Tomography: Useful Technique for Predicting Malignant Potential of Gastrointestinal Stromal Tumors. World J Surg 2005;29:1429-35.
-
(2005)
World J. Surg.
, vol.29
, pp. 1429-1435
-
-
Kamiyama, Y.1
Aihara, R.2
Nakabayashi, T.3
Mochiki, E.4
Asao, T.5
Kuwano, H.6
-
121
-
-
5544270813
-
Positron emission tomography for prostate, bladder, and renal cancer
-
Schöder H, Larson SM. Positron emission tomography for prostate, bladder, and renal cancer. Semin Nucl Med 2004;34:274-92.
-
(2004)
Semin Nucl Med.
, vol.34
, pp. 274-292
-
-
Schöder, H.1
Larson, S.M.2
-
122
-
-
0033253147
-
The increased accumulation of [18F]fluorodeoxyglucose in untreated prostate cancer
-
Oyama N, Akino H, Suzuki Y, Kanamaru H, Sadato N, Yonekura Y, et al. The increased accumulation of [18F]fluorodeoxyglucose in untreated prostate cancer. Jpn J Clin Oncol 1999;29:623-9.
-
(1999)
Jpn. J. Clin. Oncol.
, vol.29
, pp. 623-629
-
-
Oyama, N.1
Akino, H.2
Suzuki, Y.3
Kanamaru, H.4
Sadato, N.5
Yonekura, Y.6
-
123
-
-
36849044614
-
11C-choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy
-
Reske SN, Blumstein NM, Glatting G. 11C-choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy. Eur J Nucl Med Mol Imaging 2008;35:9-17.
-
(2008)
Eur. J. Nucl Med. Mol. Imaging
, vol.35
, pp. 9-17
-
-
Reske, S.N.1
Blumstein, N.M.2
Glatting, G.3
-
124
-
-
0029888387
-
Metastatic prostate cancer: Initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose
-
Shreve PD, Grossman HB, Gross MD, Wahl RL. Metastatic prostate cancer: Initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose. Radiology 1996;199:751-6.
-
(1996)
Radiology
, vol.199
, pp. 751-756
-
-
Shreve, P.D.1
Grossman, H.B.2
Gross, M.D.3
Wahl, R.L.4
-
125
-
-
67649376668
-
PET/CT with (11) C-choline and (18) F-FDG in patients with elevated PSA after radical treatment of a prostate cancer
-
García JR, Soler M, Blanch MA, Ramírez I, Riera E, Lozano P, et al. PET/CT with (11) C-choline and (18) F-FDG in patients with elevated PSA after radical treatment of a prostate cancer. Rev Esp Med Nucl 2009;28:95-100.
-
(2009)
Rev. Esp Med. Nucl
, vol.28
, pp. 95-100
-
-
García, J.R.1
Soler, M.2
Blanch, M.A.3
Ramírez, I.4
Riera, E.5
Lozano, P.6
-
126
-
-
70349348936
-
Prospective study of [18F]flluorodeoxyglucose positron emission tomography/computed tomography for staging of muscleinvasive bladder carcinoma
-
Kibel AS, Dehdashti F, Katz MD, Klim AP, Grubb RL, Humphrey PA, et al. Prospective study of [18F]flluorodeoxyglucose positron emission tomography/computed tomography for staging of muscleinvasive bladder carcinoma. J Clin Oncol 2009;27:4314-20.
-
(2009)
J. Clin. Oncol.
, vol.27
, pp. 4314-4320
-
-
Kibel, A.S.1
Dehdashti, F.2
Katz, M.D.3
Klim, A.P.4
Grubb, R.L.5
Humphrey, P.A.6
-
127
-
-
0036383491
-
Visualisation of bladder cancer using (11) C-choline PET: First clinical experience
-
de Jong IJ, Pruim J, Elsinga PH, Jongen MM, Mensink HJ, Vaalburg W. Visualisation of bladder cancer using (11) C-choline PET: First clinical experience. Eur J Nucl Med Mol Imaging 2002;29:1283-8.
-
(2002)
Eur. J. Nucl Med. Mol. Imaging
, vol.29
, pp. 1283-1288
-
-
De Jong, I.J.1
Pruim, J.2
Elsinga, P.H.3
Jongen, M.M.4
Mensink, H.J.5
Vaalburg, W.6
-
128
-
-
0036147061
-
The usefulness of F-18 deoxyglucose whole-body positron emission tomography (PET) for re-staging of renal cell cancer
-
Safaei A, Figlin R, Hoh CK, Silverman DH, Seltzer M, Phelps ME, et al. The usefulness of F-18 deoxyglucose whole-body positron emission tomography (PET) for re-staging of renal cell cancer. Clin Nephrol 2002;57:56-62.
-
(2002)
Clin. Nephrol.
, vol.57
, pp. 56-62
-
-
Safaei, A.1
Figlin, R.2
Hoh, C.K.3
Silverman, D.H.4
Seltzer, M.5
Phelps, M.E.6
-
129
-
-
0141670441
-
Efficiency of [18F]F18-FDG-PETin characterizing renal cancer and detecting distant metastases: A comparison with CT
-
Aide N, Cappele O, Bottet P, Bensadoun H, Regeasse A, Comoz F, et al. Efficiency of [18F]F18-FDG-PETin characterizing renal cancer and detecting distant metastases: A comparison with CT. Eur J Nucl Med Mol Imaging 2003;30:1236-45.
-
(2003)
Eur. J. Nucl Med. Mol. Imaging
, vol.30
, pp. 1236-1245
-
-
Aide, N.1
Cappele, O.2
Bottet, P.3
Bensadoun, H.4
Regeasse, A.5
Comoz, F.6
-
130
-
-
5544226307
-
Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma
-
Kang DE, White RL Jr, Zuger JH, Sasser HC, Teigland CM. Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma. J Urol 2004;171:1806-9.
-
(2004)
J. Urol.
, vol.171
, pp. 1806-1809
-
-
Kang, D.E.1
White Jr., R.L.2
Zuger, J.H.3
Sasser, H.C.4
Teigland, C.M.5
-
131
-
-
33644857682
-
2-Deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography in characterization of solid renal masses
-
Kumar R, Chauhan A, Lakhani P, Xiu Y, Zhuang H, Alavi A. 2-Deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography in characterization of solid renal masses. Mol Imaging Biol 2005;7:431-9.
-
(2005)
Mol. Imaging Biol.
, vol.7
, pp. 431-439
-
-
Kumar, R.1
Chauhan, A.2
Lakhani, P.3
Xiu, Y.4
Zhuang, H.5
Alavi, A.6
-
132
-
-
60849092923
-
18F-FDG PET/CT imaging for an early assessment of response to sunitinib in metastatic renal carcinoma: Preliminary study
-
Vercellino L, Bousquet G, Baillet G, Barré E, Mathieu O, Just PA, et al. 18F-FDG PET/CT imaging for an early assessment of response to sunitinib in metastatic renal carcinoma: Preliminary study. Cancer Biother Radiopharm 2009;24:137-44.
-
(2009)
Cancer Biother Radiopharm
, vol.24
, pp. 137-144
-
-
Vercellino, L.1
Bousquet, G.2
Baillet, G.3
Barré, E.4
Mathieu, O.5
Just, P.A.6
-
133
-
-
0034061024
-
Fluorodeoxyglucose PET in the initial staging of germ cell tumours
-
Hain SF, O'Doherty MJ, Timothy AR, Leslie MD, Partridge SE, Huddart RA. Fluorodeoxyglucose PET in the initial staging of germ cell tumours. Eur J Nucl Med 2000;27:590-4.
-
(2000)
Eur. J. Nucl Med.
, vol.27
, pp. 590-594
-
-
Hain, S.F.1
O'Doherty, M.J.2
Timothy, A.R.3
Leslie, M.D.4
Partridge, S.E.5
Huddart, R.A.6
-
134
-
-
0036009352
-
Diagnostic value of 18F-FDG positron emission tomography for detection and treatment control of malignant germ cell tumors
-
Tsatalpas P, Beuthien-Baumann B, Kropp J, Manseck A, Tiepolt C, Hakenberg OW, et al. Diagnostic value of 18F-FDG positron emission tomography for detection and treatment control of malignant germ cell tumors. Urol Int 2002;68:157-63.
-
(2002)
Urol. Int.
, vol.68
, pp. 157-163
-
-
Tsatalpas, P.1
Beuthien-Baumann, B.2
Kropp, J.3
Manseck, A.4
Tiepolt, C.5
Hakenberg, O.W.6
-
135
-
-
0036343610
-
The role of (18) fluoro-2-deoxyglucose positron emission tomography in initial staging and restaging after chemotherapy for testicular germ cell tumours
-
Spermon JR, De Geus-Oei LF, Kiemeney LA, Witjes JA, Oyen WJ. The role of (18) fluoro-2-deoxyglucose positron emission tomography in initial staging and restaging after chemotherapy for testicular germ cell tumours. BJU Int 2002;89:549-56.
-
(2002)
BJU Int.
, vol.89
, pp. 549-556
-
-
Spermon, J.R.1
De Geus-Oei, L.F.2
Kiemeney, L.A.3
Witjes, J.A.4
Oyen, W.J.5
-
136
-
-
0037870283
-
Whole-body FDG-PET in patients with stage I non-seminomatous germ cell tumours
-
Lassen U, Daugaard G, Eigtved A, Højgaard L, Damgaard K, Rørth M. Whole-body FDG-PET in patients with stage I non-seminomatous germ cell tumours. Eur J Nucl Med Mol Imaging 2003;30:396-402.
-
(2003)
Eur. J. Nucl Med. Mol. Imaging
, vol.30
, pp. 396-402
-
-
Lassen, U.1
Daugaard, G.2
Eigtved, A.3
Højgaard, L.4
Damgaard, K.5
Rørth, M.6
-
137
-
-
28844468964
-
Nuclear medicine studies of the prostate, testes, and bladder
-
Jana S, Blaufox MD. Nuclear medicine studies of the prostate, testes, and bladder. Semin Nucl Med 2006;36:51-72.
-
(2006)
Semin Nucl Med.
, vol.36
, pp. 51-72
-
-
Jana, S.1
Blaufox, M.D.2
-
138
-
-
0035449028
-
Predictive impact of 2-18fluoro-2-deoxy-D-glucose positron emission tomography for residual postchemotherapy masses in patients with bulky seminoma
-
De Santis M, Bokemeyer C, Becherer A, Stoiber F, Oechsle K, Kletter K, et al. Predictive impact of 2-18fluoro-2-deoxy-D-glucose positron emission tomography for residual postchemotherapy masses in patients with bulky seminoma. J Clin Oncol 2001;19:3740-4.
-
(2001)
J. Clin. Oncol.
, vol.19
, pp. 3740-3744
-
-
De Santis, M.1
Bokemeyer, C.2
Becherer, A.3
Stoiber, F.4
Oechsle, K.5
Kletter, K.6
-
139
-
-
20244368226
-
FDG PET is superior to CT in the prediction of viable tumor in post-chemotherapy seminoma residuals
-
Becherer A, De Santis M, Karanikas G, Szabó M, Bokemeyer C, Dohmen BM, et al. FDG PET is superior to CT in the prediction of viable tumor in post-chemotherapy seminoma residuals. Eur J Radiol 2005;54:284-8.
-
(2005)
Eur. J. Radiol.
, vol.54
, pp. 284-288
-
-
Becherer, A.1
De Santis, M.2
Karanikas, G.3
Szabó, M.4
Bokemeyer, C.5
Dohmen, B.M.6
-
140
-
-
16844369124
-
The radionuclide molecular imaging and therapy of neuroendocrine tumors
-
Li S, Beheshti M. The radionuclide molecular imaging and therapy of neuroendocrine tumors. Curr Cancer Drug Targets 2005;5:139-48.
-
(2005)
Curr. Cancer Drug. Targets
, vol.5
, pp. 139-148
-
-
Li, S.1
Beheshti, M.2
-
141
-
-
14844323979
-
Developments in PET for the detection of endocrine tumours
-
Eriksson B, Orlefors H, Oberg K, Sundin A, Bergström M, Långström B. Developments in PET for the detection of endocrine tumours. Best Pract Res Clin Endocrinol Metab 2005;19:311-24.
-
(2005)
Best Pract. Res. Clin. Endocrinol. Metab.
, vol.19
, pp. 311-324
-
-
Eriksson, B.1
Orlefors, H.2
Oberg, K.3
Sundin, A.4
Bergström, M.5
Långström, B.6
-
142
-
-
0036007324
-
Pheochromocytomas: Detection with 18F DOPA whole body PET-initial results
-
Hoegerle S, Nitzsche E, Altehoefer C, Ghanem N, Manz T, Brink I, et al. Pheochromocytomas: Detection with 18F DOPA whole body PET-initial results. Radiology 2002;222:507-12.
-
(2002)
Radiology
, vol.222
, pp. 507-512
-
-
Hoegerle, S.1
Nitzsche, E.2
Altehoefer, C.3
Ghanem, N.4
Manz, T.5
Brink, I.6
-
144
-
-
3242662501
-
Anatomical and functional imaging of metastatic pheochromocytoma
-
Ilias I, Pacak K. Anatomical and functional imaging of metastatic pheochromocytoma. Ann N Y Acad Sci 2004;1018:495-504.
-
(2004)
Ann. N y Acad. Sci.
, vol.1018
, pp. 495-504
-
-
Ilias, I.1
Pacak, K.2
-
145
-
-
0037024508
-
Diagnostic localization of pheochromocytoma: The coming of age of positron emission tomography
-
Pacak K, Eisenhofer G, Carrasquillo JA, Chen CC, Whatley M, Goldstein DS. Diagnostic localization of pheochromocytoma: The coming of age of positron emission tomography. Ann N Y Acad Sci 2002;970:170-6.
-
(2002)
Ann. N y Acad. Sci.
, vol.970
, pp. 170-176
-
-
Pacak, K.1
Eisenhofer, G.2
Carrasquillo, J.A.3
Chen, C.C.4
Whatley, M.5
Goldstein, D.S.6
-
146
-
-
1342328545
-
Pheochromocytomas: Detection with 11C hydroxyephedrine PET
-
Trampal C, Engler H, Juhlin C, Bergström M, Långström B. Pheochromocytomas: Detection with 11C hydroxyephedrine PET. Radiology 2004;230:423-8.
-
(2004)
Radiology
, vol.230
, pp. 423-428
-
-
Trampal, C.1
Engler, H.2
Juhlin, C.3
Bergström, M.4
Långström, B.5
-
147
-
-
13844321911
-
Metastatic carcinoid tumors: A clinical review
-
Zuetenhorst JM, Taal BG. Metastatic carcinoid tumors: A clinical review. Oncologist 2005;10:123-31.
-
(2005)
Oncologist
, vol.10
, pp. 123-131
-
-
Zuetenhorst, J.M.1
Taal, B.G.2
-
148
-
-
0034742715
-
Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors
-
Hoegerle S, Altehoefer C, Ghanem N, Koehler G, Waller CF, Scheruebl H, et al. Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors. Radiology 2001;220:373-80.
-
(2001)
Radiology
, vol.220
, pp. 373-380
-
-
Hoegerle, S.1
Altehoefer, C.2
Ghanem, N.3
Koehler, G.4
Waller, C.F.5
Scheruebl, H.6
-
150
-
-
65349131321
-
Update on nuclear medicine imaging of neuroendocrine tumors
-
Goldsmith SJ. Update on nuclear medicine imaging of neuroendocrine tumors. Future Oncol 2009;5:75-84.
-
(2009)
Future Oncol.
, vol.5
, pp. 75-84
-
-
Goldsmith, S.J.1
-
151
-
-
16644393039
-
18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer
-
Kumar R, Xiu Y, Yu JQ, Takalkar A, El-Haddad G, Potenta S, et al. 18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer. J Nucl Med 2004;45:2058-62.
-
(2004)
J. Nucl Med.
, vol.45
, pp. 2058-2062
-
-
Kumar, R.1
Xiu, Y.2
Yu, J.Q.3
Takalkar, A.4
El-Haddad, G.5
Potenta, S.6
-
152
-
-
3242703395
-
Imaging of adrenal incidentalomas with PET using (11) C-metomidate and (18) F-FDG
-
Minn H, Salonen A, Friberg J, Roivainen A, Viljanen T, Långsjö J, et al. Imaging of adrenal incidentalomas with PET using (11) C-metomidate and (18) F-FDG. J Nucl Med 2004;45:972-9.
-
(2004)
J. Nucl Med.
, vol.45
, pp. 972-979
-
-
Minn, H.1
Salonen, A.2
Friberg, J.3
Roivainen, A.4
Viljanen, T.5
Långsjö, J.6
-
153
-
-
28944446237
-
FDG-PET and CT characterization of adrenal lesions in cancer patients
-
Jana S, Zhang T, Milstein DM, Isasi CR, Blaufox MD. FDG-PET and CT characterization of adrenal lesions in cancer patients. Eur J Nucl Med Mol Imaging 2006;33:29-35.
-
(2006)
Eur. J. Nucl Med. Mol. Imaging
, vol.33
, pp. 29-35
-
-
Jana, S.1
Zhang, T.2
Milstein, D.M.3
Isasi, C.R.4
Blaufox, M.D.5
-
154
-
-
0035542957
-
18F-FDG PET in characterizing adrenal lesions detected on CT or MRI
-
Yun M, Kim W, Alnafisi N, Lacorte L, Jang S, Alavi A. 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. J Nucl Med 2001;42:1795-9.
-
(2001)
J. Nucl Med.
, vol.42
, pp. 1795-1799
-
-
Yun, M.1
Kim, W.2
Alnafisi, N.3
Lacorte, L.4
Jang, S.5
Alavi, A.6
-
155
-
-
0036715553
-
Clinical role of positron emission tomography (PET) in endocrine tumours
-
Rubello D, Rufini V, Casara D, Calcagni ML, Samanes Gajate AM, Shapiro B. Clinical role of positron emission tomography (PET) in endocrine tumours. Panminerva Med.2002;44:185-96.
-
(2002)
Panminerva Med.
, vol.44
, pp. 185-196
-
-
Rubello, D.1
Rufini, V.2
Casara, D.3
Calcagni, M.L.4
Gajate, A.M.S.5
Shapiro, B.6
-
156
-
-
0033975202
-
PET imaging of adrenal cortical tumors with the 11ß-hydroxylase tracer 11C-metomidate
-
Bergström M, Juhlin C, Bonasera TA, Sundin A, Rastad J, Akerström G, et al. PET imaging of adrenal cortical tumors with the 11ß-hydroxylase tracer 11C-metomidate. J Nucl Med 2000;41:275-82.
-
(2000)
J. Nucl Med.
, vol.41
, pp. 275-282
-
-
Bergström, M.1
Juhlin, C.2
Bonasera, T.A.3
Sundin, A.4
Rastad, J.5
Akerström, G.6
-
157
-
-
0031838388
-
In vitro and in vivo primate evaluation of carbon-11-etomidate and carbon-11-metomidate as potential tracers for PET imaging of the adrenal cortex and its tumors
-
Bergström M, Bonasera TA, Lu L, Bergström E, Backlin C, Juhlin C, et al. In vitro and in vivo primate evaluation of carbon-11-etomidate and carbon-11-metomidate as potential tracers for PET imaging of the adrenal cortex and its tumors. J Nucl Med 1998;39:982-9.
-
(1998)
J. Nucl Med.
, vol.39
, pp. 982-989
-
-
Bergström, M.1
Bonasera, T.A.2
Lu, L.3
Bergström, E.4
Backlin, C.5
Juhlin, C.6
-
158
-
-
5544229749
-
2-deoxy-fluorglucosepositron emission tomography imaging of the brain: Current clinical applications with emphasis on the dementias
-
Van Heertum RL, Greenstein EA, Tikofsky RS. 2-deoxy-fluorglucosepositron emission tomography imaging of the brain: Current clinical applications with emphasis on the dementias. Semin Nucl Med 2004;34:300-12.
-
(2004)
Semin Nucl Med.
, vol.34
, pp. 300-312
-
-
Van Heertum, R.L.1
Greenstein, E.A.2
Tikofsky, R.S.3
-
159
-
-
0031016159
-
18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma
-
Barker FG 2nd, Chang SM, Valk PE, Pounds TR, Prados MD. 18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma. Cancer 1997;79:115-26.
-
(1997)
Cancer
, vol.79
, pp. 115-126
-
-
Barker II, F.G.1
Chang, S.M.2
Valk, P.E.3
Pounds, T.R.4
Prados, M.D.5
-
160
-
-
16344393239
-
18F-FDG PET of gliomas at delayed intervals: Improved distinction between tumor and normal gray matter
-
Spence AM, Muzi M, Mankoff DA, O'Sullivan SF, Link JM, Lewellen TK, et al. 18F-FDG PET of gliomas at delayed intervals: Improved distinction between tumor and normal gray matter. J Nucl Med 2004;45:1653-9.
-
(2004)
J. Nucl Med.
, vol.45
, pp. 1653-1659
-
-
Spence, A.M.1
Muzi, M.2
Mankoff, D.A.3
O'Sullivan, S.F.4
Link, J.M.5
Lewellen, T.K.6
-
161
-
-
0031596996
-
11C-methionine PET for differential diagnosis of low-grade gliomas
-
Herholz K, Hölzer T, Bauer B, Schröder R, Voges J, Ernestus RI, et al. 11C-methionine PET for differential diagnosis of low-grade gliomas. Neurology 1998;50:1316-22.
-
(1998)
Neurology
, vol.50
, pp. 1316-1322
-
-
Herholz, K.1
Hölzer, T.2
Bauer, B.3
Schröder, R.4
Voges, J.5
Ernestus, R.I.6
-
162
-
-
23044460494
-
Imaging proliferation in brain tumors with 18F-FLT PET: Comparison with 18F-FDG
-
Chen W, Cloughesy T, Kamdar N, Satyamurthy N, Bergsneider M, Liau L, et al. Imaging proliferation in brain tumors with 18F-FLT PET: Comparison with 18F-FDG. J Nucl Med 2005;46:945-52.
-
(2005)
J. Nucl Med.
, vol.46
, pp. 945-952
-
-
Chen, W.1
Cloughesy, T.2
Kamdar, N.3
Satyamurthy, N.4
Bergsneider, M.5
Liau, L.6
-
163
-
-
14844320869
-
Multimodal metabolic imaging of cerebral gliomas: Positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy
-
Floeth FW, Pauleit D, Wittsack HJ, Langen KJ, Reifenberger G, Hamacher K, et al. Multimodal metabolic imaging of cerebral gliomas: Positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy. J Neurosurg 2005;102:318-27.
-
(2005)
J. Neurosurg.
, vol.102
, pp. 318-327
-
-
Floeth, F.W.1
Pauleit, D.2
Wittsack, H.J.3
Langen, K.J.4
Reifenberger, G.5
Hamacher, K.6
-
164
-
-
15044344615
-
O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas
-
Pauleit D, Floeth F, Hamacher K, Riemenschneider MJ, Reifenberger G, Müller HW, et al. O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas. Brain 2005;128:678-87.
-
(2005)
Brain
, vol.128
, pp. 678-687
-
-
Pauleit, D.1
Floeth, F.2
Hamacher, K.3
Riemenschneider, M.J.4
Reifenberger, G.5
Müller, H.W.6
|